People · Operator

Lloyd C. Chesney

Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology

1
Companies
1
Filings
$3.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Vicor Technologies, Inc.BiotechnologySeed$3.7M$120.6M2010
Operator network

Lloyd C. Chesney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Frederick M. Hudson · 2 companies · 1 sharedFrederick M. Huds…James E. Skinner · 2 companies · 1 sharedJames E. SkinnerDaniel H. Weiss · 1 companies · 1 sharedDaniel H. WeissDaniel N. Weiss · 1 companies · 1 sharedDaniel N. WeissDavid H. Fater · 1 companies · 1 sharedDavid H. FaterEdward H. Wiesmeier · 1 companies · 1 sharedEdward H. Wiesmei…Edward M. Wiesmeier · 1 companies · 1 sharedEdward M. Wiesmei…Edward Wiesmeier · 1 companies · 1 sharedEdward WiesmeierJames H. Skinner · 1 companies · 1 sharedJames H. SkinnerJerry H. Anchin · 1 companies · 1 sharedJerry H. AnchinJerry M. Anchin · 1 companies · 1 sharedJerry M. AnchinJoseph A. Franchetti · 1 companies · 1 sharedJoseph A. Franche…Thomas J. Bohannon · 1 companies · 1 sharedThomas J. BohannonVicor Technologies, Inc. · $3.7M raisedVicor Technologies, I…Lloyd C. ChesneyLC
Lloyd C. Chesney Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Lloyd C. Chesney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Frederick M. Hudson12
James E. Skinner12
Joseph A. Franchetti11
Daniel N. Weiss11
Jerry M. Anchin11
David H. Fater11
Thomas J. Bohannon11
Edward M. Wiesmeier11
Edward H. Wiesmeier11
Daniel H. Weiss11
Jerry H. Anchin11
James H. Skinner11
Edward Wiesmeier11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.